Key result
In a 52-year-old male with a heterotopic cardiac transplant, ventricular tachycardia in the native heart accelerated following propofol induction but was successfully treated by cardioversion.
Case Report (n=1)
Propofol induction may accelerate ventricular tachycardia in patients with heterotopic cardiac transplants, though synchronized cardioversion remains an effective treatment.
Answers are grounded in this paper and cite their sources.
Propofol may accelerate native-heart VT in heterotopic transplant recipients; hypothesis-generating and should not yet change practice.
A 52-year-old Caucasian male underwent heterotopic cardiac transplant and subsequently developed a ventricular tachycardia in his native heart. The arrhythmia was successfully treated by cardioversion, despite an increased rate associated with induction of anaesthesia with propofol. The method of synchronised cardioversion is described and a possible hypothesis for the acceleration of ventricular tachycardia following induction is discussed.
No takes yet. Share an insight, caveat, or question.
Jayamaha et al. (1993) conducted a case report in Ventricular tachycardia following heterotopic cardiac transplant (n=1). Propofol induction and cardioversion was evaluated on Successful treatment of ventricular tachycardia. In a 52-year-old male with a heterotopic cardiac transplant, ventricular tachycardia in the native heart accelerated following propofol induction but was successfully treated by cardioversion.
Synapse has enriched 10 related papers. Consider them for comparative context: